Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_assertion type Assertion NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_head.
- NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_assertion description "[In 433 subjects from a community primary stroke prevention program, blood levels of active MMP-1, total and active MMP-3 and active MMP-9 were determined using enzyme-linked immunosorbent assays, carotid plaque score (PS) and IMT by high-resolution B-mode ultrasonography and the common MMP-1, MMP-3, and MMP-9 promoter low- and high-activity genotypes by polymerase chain reaction and restriction fragment length polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_provenance.
- NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_assertion evidence source_evidence_literature NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_provenance.
- NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_assertion SIO_000772 20609440 NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_provenance.
- NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_assertion wasDerivedFrom befree-20140225 NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_provenance.
- NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_assertion wasGeneratedBy ECO_0000203 NP628384.RAxIOl2VnwX_NJCDOcY-1NUwHq3oDX4o2G5nFBze3OaEI130_provenance.